Skip to content

COVID-19 Vaccine Confidence Among Pregnant Women and Mothers

Vaccine Confidence Among Pregnant Women and Mothers During the COVID-19 Pandemic

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT04694664
Acronym
VCCOVID
Enrollment
18000
Registered
2021-01-05
Start date
2020-10-01
Completion date
2020-12-01
Last updated
2021-01-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Mothers, Pregnancy Related

Brief summary

The purpose of this study is to assess the level of vaccine confidence and influencers among pregnant women and mothers of school-aged children during the COVID-19 pandemic.

Detailed description

The WHO has listed vaccine hesitancy as one of the top threats to global health. The COVID-19 pandemic has triggered the need to vaccinate worldwide as soon as a safe and efficacious vaccine becomes available. However preliminary data show that, on average, only 50% to 66% of US adults would be willing to receive COVID-19 vaccination when it becomes available, a percentage lower than what is required for herd immunity to control the pandemic. Furthermore, there is a pressing need to vaccinate children to reopen schools and keeping them safe, as well as to immunize pregnant women through vaccination programs since they constitute a vulnerable population. Vaccine confidence among pregnant women and mothers of school-aged children during the period of COVID-19 pandemic is unknown, leading to an important gap of knowledge that may hinder the upcoming global COVID-19 vaccination scale-up effort. It is therefore of critical importance to assess the level of vaccine confidence and influencers among pregnant women and mothers of school-aged children during the COVID-19 pandemic. The international nature of the proposed survey will allow the evaluation of vaccine confidence and its influencers among pregnant women and mothers of school-aged children on a global level. Therefore, social and geographic characteristics from different countries and cultures will be available for comparison. The resulting knowledge will be relevant to a large percentage of the world's population. Any country in the world can participate.

Interventions

As this is an online survey about health and wellbeing, there is no intervention.

Sponsors

Harvard School of Public Health (HSPH)
CollaboratorOTHER
Pregistry
Lead SponsorINDUSTRY

Study design

Observational model
COHORT
Time perspective
CROSS_SECTIONAL

Eligibility

Sex/Gender
FEMALE
Age
18 Years to 65 Years
Healthy volunteers
Yes

Inclusion criteria

* Pregnant women or women who have at least one child younger than 18 years of age. Able to give electronic informed consent

Exclusion criteria

* \<18 years of age

Design outcomes

Primary

MeasureTime frameDescription
Percentage of acceptance of a COVID-19 vaccineup to 2 monthsThis outcome will evaluate the hesitancy or acceptance to a COVID-19 vaccine

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026